INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 414m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN14m ago
Public company

NUTXNutex Health Inc.

CIK 0001479681

EDGAR filingsOpen in network
Disclosed transactions22
Buys / sells3 / 1
Max Insider Score42
Connections8with evidence

NUTX · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
29
SJ
Saunders Scott JDirector
NUTXNutex Health Inc.
Open-market sale
SELL$43K
203 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • ← Insider ofevidence
    Vo Thomas T.Director, Chief Executive Officer · Apr 10, 2026
  • ← Insider ofevidence
    Bamburg Wesley ShaneChief Operating Officer · Mar 24, 2026
  • ← Insider ofevidence
    Montgomery Pamela W.Chief Legal Officer-Healthcare · Mar 16, 2026
  • ← Insider ofevidence
    Spears KelvinDirector · Mar 11, 2026
12
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Other acquisition or disposition
J
—
2,519 sh
Jun 4, 2026
Jun 4, 2026
traded Jun 4, 2026
+0d
SEC FORM 4

Evidence

12
VT
Vo Thomas T.Director, Chief Executive Officer
NUTXNutex Health Inc.
Other acquisition or disposition
J—
75.7K sh
May 28, 2026May 29, 2026
traded May 28, 2026
+1dSEC FORM 4

Evidence

21
SJ
Saunders Scott JDirector
NUTXNutex Health Inc.
Grant or award
A—
823 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC FORM 4

Evidence

21
RL
Reed Michael LeeDirector
NUTXNutex Health Inc.
Grant or award
A—
823 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC FORM 4

Evidence

21
GY
Grenas Cheryl YvonneDirector
NUTXNutex Health Inc.
Grant or award
A—
823 sh
Apr 23, 2026Apr 24, 2026
traded Apr 23, 2026
+1dSEC FORM 4

Evidence

27
VT
Vo Thomas T.Director, Chief Executive Officer
NUTXNutex Health Inc.
Option exercise
M—
4,841 sh
Mar 10, 2026Apr 10, 2026
traded Mar 10, 2026
+31dSEC FORM 4

Evidence

16
VT
Vo Thomas T.Director, Chief Executive Officer
NUTXNutex Health Inc.
Other acquisition or disposition
J—
184.1K sh
Apr 9, 2026Apr 10, 2026
traded Apr 9, 2026
+1dSEC FORM 4

Evidence

19
BS
Bamburg Wesley ShaneChief Operating Officer
NUTXNutex Health Inc.
Option exercise
M—
2,411 sh
Mar 11, 2026Mar 24, 2026
traded Mar 11, 2026
+13dSEC FORM 4

Evidence

34
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Open-market purchase
BUY$945
10 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC FORM 4

Evidence

31
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Option exercise
M—
116 sh
Mar 10, 2026Mar 18, 2026
traded Mar 10, 2026
+8dSEC FORM 4

Evidence

34
MW
Montgomery Pamela W.Chief Legal Officer-Healthcare
NUTXNutex Health Inc.
Open-market purchase
BUY$7,021
79 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

27
MW
Montgomery Pamela W.Chief Legal Officer-Healthcare
NUTXNutex Health Inc.
Option exercise
M—
1,523 sh
Mar 10, 2026Mar 16, 2026
traded Mar 10, 2026
+6dSEC FORM 4

Evidence

13
BC
Bates Jon ChristianChief Financial Officer
NUTXNutex Health Inc.
Option exercise
M—
2,667 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC FORM 4

Evidence

9
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Option exercise
M—
183 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC FORM 4

Evidence

9
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Tax withholding
F$7,070
82 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC FORM 4

Evidence

17
SK
Spears KelvinDirector
NUTXNutex Health Inc.
Option exercise
M—
116 sh
Mar 10, 2026Mar 11, 2026
traded Mar 10, 2026
+1dSEC FORM 4

Evidence

13
BC
Bates Jon ChristianChief Financial Officer
NUTXNutex Health Inc.
Option exercise
M—
1,694 sh
Mar 11, 2026Mar 11, 2026
traded Mar 11, 2026
+0dSEC FORM 4

Evidence

24
GY
Grenas Cheryl YvonneDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC FORM 4

Evidence

24
SJ
Saunders Scott JDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC FORM 4

Evidence

24
RL
Reed Michael LeeDirector
NUTXNutex Health Inc.
Grant or award
A—
603 sh
Jul 14, 2025Feb 9, 2026
traded Jul 14, 2025
+210dSEC FORM 4

Evidence

42
BC
Bates Jon ChristianChief Financial Officer
NUTXNutex Health Inc.
Open-market purchase
BUY$103K
750 sh
Nov 25, 2025Nov 28, 2025
traded Nov 25, 2025
+3dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Saunders Scott JDirector · Feb 9, 2026
  • ← Insider ofevidence
    Reed Michael LeeDirector · Feb 9, 2026
  • ← Insider ofevidence
    Grenas Cheryl YvonneDirector · Feb 9, 2026
  • ← Insider ofevidence
    Bates Jon ChristianChief Financial Officer · Nov 28, 2025